Orange Book product · Brand (NDA)
MICRO-K LS
POTASSIUM CHLORIDE
At a glance
Aug 26, 1988
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 26, 1988
38 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
POTASSIUM CHLORIDE
Strength
20MEQ/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
FOR SUSPENSION, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 019561
Product number
003
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2023POKONZABrand (NDA)
NDA 208019 · GENUS
- —MICRO-KBrand (NDA)
NDA 018238 · NESHER PHARMS
- —POTASSIUM CHLORIDEBrand (NDA)
NDA 007865 · LILLY
- 2025POTASSIUM CHLORIDEGeneric (ANDA)
ANDA 219009 · ANDA REPOSITORY
- 2023POTASSIUM CHLORIDEGeneric (ANDA)
ANDA 212816 · NOVITIUM PHARMA
- 2022POTASSIUM CHLORIDEGeneric (ANDA)
ANDA 214108 · RUBICON RESEARCH
- 2022POTASSIUM CHLORIDEGeneric (ANDA)
ANDA 213467 · GRANULES
- 2021POTASSIUM CHLORIDEGeneric (ANDA)
ANDA 211667 · STRIDES PHARMA
- 2021POTASSIUM CHLORIDEGeneric (ANDA)
ANDA 214686 · GRANULES
- 2019POTASSIUM CHLORIDEGeneric (ANDA)
ANDA 209026 · PRINSTON INC
- 2019POTASSIUM CHLORIDEGeneric (ANDA)
ANDA 210902 · AMNEAL
- 2019POTASSIUM CHLORIDEGeneric (ANDA)
ANDA 212183 · AJENAT PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
